Global Neurology Academy
The Global Neurology Academy (GNA) series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.
For more information about GNA, visit www.globalneurologyacademy.org.
Episodes 1-15 of 183
Negative Symptoms in Schizophrenia: Identifying and Managing the Hidden Burden
On the Frontlines of SchizophreniaNegative Symptoms in Schizophrenia: Identifying and Managing the Hidden Burden
Advancing Schizophrenia Care: When and How to Use Novel Therapies in Complex Patients
NeuroFrontiersAdvancing Schizophrenia Care: When and How to Use Novel Therapies in Complex Patients
Using fMRI to Identify Early Alzheimer’s Disease Subgroups
NeuroFrontiersUsing fMRI to Identify Early Alzheimer’s Disease Subgroups
Evaluating AR1001: A Phase 3 Trial in Early Alzheimer’s Disease
NeuroFrontiersEvaluating AR1001: A Phase 3 Trial in Early Alzheimer’s Disease
Understanding Schizophrenia: The Role of Neurotransmission and Inflammation
NeuroFrontiersUnderstanding Schizophrenia: The Role of Neurotransmission and Inflammation
Harnessing AI to Predict and Prevent Schizophrenia Relapse
NeuroFrontiersHarnessing AI to Predict and Prevent Schizophrenia Relapse
- advertisement
Engaging Patients and Caregivers in Schizophrenia: A Collaborative Care Approach
NeuroFrontiersEngaging Patients and Caregivers in Schizophrenia: A Collaborative Care Approach
Applying CBT for Psychosis in Schizophrenia Care: Strategies for Expanding Access
NeuroFrontiersApplying CBT for Psychosis in Schizophrenia Care: Strategies for Expanding Access
Improving Survival and Function in Pediatric TK2d with Nucleoside Therapy
Clinician's RoundtableImproving Survival and Function in Pediatric TK2d with Nucleoside Therapy
Optimizing Generalized Myasthenia Gravis Care Through Patient-Centered Choices
NeuroFrontiersOptimizing Generalized Myasthenia Gravis Care Through Patient-Centered Choices
Timing Meningococcal Vaccines in gMG: Challenges and Considerations
NeuroFrontiersTiming Meningococcal Vaccines in gMG: Challenges and Considerations
Individualizing gMG Treatment: Defining Success With Each Patient
NeuroFrontiersIndividualizing gMG Treatment: Defining Success With Each Patient
- advertisement
Optimizing the Role for Corticosteroids Within the Evolving DMD Treatment Landscape
CME/CEOptimizing the Role for Corticosteroids Within the Evolving DMD Treatment Landscape
Linking Obesity to Alzheimer’s: The Lipid Signals Driving Neurodegeneration
Clinician's RoundtableLinking Obesity to Alzheimer’s: The Lipid Signals Driving Neurodegeneration
Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
CME/CEAre All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
